Related Experiment Video
Updated: Mar 28, 2026

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
Published on: March 22, 2017
Directing Cardiomyogenic Differentiation and Transdifferentiation By Ectopic Gene Expression - Direct Transition Or
Birgit Andrée1, Robert Zweigerdt2
1Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), REBIRTH - Center for Regenerative Medicine, Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School (MHH), Carl Neuberg Str. 1, D-30625 Hannover, Germany. andree.birgit@mh-hannover.de.
New cell therapies show promise for heart repair by generating cardiomyocytes (CMs) from stem cells or directly converting other cells. Challenges remain in translating these advancements from mice to clinical applications for cardiovascular disorders.
Area of Science:
- Regenerative Medicine
- Cardiovascular Research
- Stem Cell Biology
Background:
- Cardiovascular disorders are a leading cause of global mortality, with limited natural heart regeneration and donor organ scarcity.
- Previous strategies like endogenous cardiomyocyte proliferation and adult stem cell therapy have shown limited success in heart repair.
- In vitro generated cardiomyocytes are being investigated to restore heart muscle function, necessitating sustainable cell sources.
Purpose of the Study:
- To explore the potential of induced pluripotent stem cells (iPSCs) for autologous cell therapies in cardiovascular repair.
- To review methods for efficient and safe iPSC differentiation into cardiomyocytes (CMs) and functional subtypes.
- To discuss the direct transdifferentiation of fibroblasts into induced cardiomyocyte-like cells (iCMs) as an alternative strategy.
Main Methods:
- Review of recent advancements in iPSC differentiation into CMs using ectopic expression of cardiac transcription factors or chemical modulators.
- Analysis of direct fibroblast-to-cardiomyocyte transdifferentiation (iCMs) via transcription factor combinations.
- Evaluation of studies involving in vitro and in vivo generation of iCMs.
Main Results:
- Successful differentiation of iPSCs into CMs and specific subtypes has been achieved.
- Direct transdifferentiation of fibroblasts into iCMs has been demonstrated in vitro and in vivo, proving iPSC induction is not essential.
- Most current research is based on mouse models, highlighting challenges in translating findings to large animal models and clinical settings.
Conclusions:
- Both iPSC-derived CMs and directly generated iCMs offer potential avenues for heart repair therapies.
- Significant progress has been made, but translation to clinical practice requires overcoming challenges in large animal models.
- Further research is needed to refine these methods for safe and effective clinical application in treating cardiovascular diseases.
Related Concept Videos
Forced Transdifferentiation
Artificial...
Cellular Differentiation
A zygote is a...

